Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
13 Sep 2024
Breast Cancer Screening: Risks and Benefits
A new study projects outcomes of breast cancer screening strategies using digital breast tomosynthesis with or without supplemental breast magnetic resonance imaging.
13 Sep 2024
Unmasking VEXAS: How Skin Clues Reveal a Hidden Genetic Disorder
Researchers found that skin involvement is a common and often early indicator of VEXAS syndrome, affecting 83% of patients.
13 Sep 2024
Non-Athlete Sports Concussions Not Linked to Long-Term Cognitive Impairment
A study found that sports-related concussions had no long-term cognitive effects, while repeated non-sports-related concussions were linked to cognitive decline.
12 Sep 2024
FLOW Trial Shows Benefit of Semaglutide in Type 2 Diabetes and CKD: EASD 2024
Findings from the FLOW trial, the first dedicated kidney outcomes trial with semaglutide in patients with Type 2 diabetes and chronic kidney disease, were presented at EASD 2024.
12 Sep 2024
The Silent Killer: Spotlight on Sepsis
Ron Daniels, Founder and Executive Director of UK Sepsis Trust, shatters myths and amplifies awareness around sepsis.
September 2024
EMJ Respiratory 12 [Supplement 2] 2024
Today, asthma and COPD affect more than 550 million people worldwide, representing a huge and growing burden on patients, healthcare…
8
Mins
12 Sep 2024
Transforming Asthma and COPD Care
Asthma and chronic obstructive pulmonary disease (COPD) affect more than 550 million people worldwide and are associated with substantial…
12 Sep 2024
Predictors for Weight Loss and Glucose Control with Tirzepatide: EASD 2024
New analysis from the SURPASS-4 trial identifies crucial factors for maintaining blood glucose control and weight loss with tirzepatide in patients with Type 2 diabetes.
12 Sep 2024
The ITP Treatment Landscape
In this video, discover updates in the treatment of immune thrombocytopaenia, with a focus on patient perspectives and unmet clinical needs.
12 Sep 2024
Early Control of Gestational Diabetes Reduces Childhood Obesity Risk: EASD 2024
A key study presented at EASD 2024 highlights that rapidly managing blood sugar in pregnant women with gestational diabetes reduces the risk of obesity in their children.
←
1
2
3
…
103
104
105
106
107
108
109
…
993
994
995
→